fbpx
CAS Insight

molecules of the month

February 2021

February was a packed month for interesting molecules – there were nearly 20 molecules we thought about including in this list but couldn’t fit them all. There are several clinical candidates this month including mobocertinib, an exon 20 mutant inhibitor that was recently given Breakthrough Therapy Designation by the FDA. Also included are several interesting modes of action here including two degraders, multiple protein dimerizers, and a mechanism-based inhibitor that modifies its target’s substrate. Finally, chemists will appreciate some interesting structures on this list as well as the femtomolar inhibitor CPI-1328 with a reversible potency among the strongest ever recorded.

Join the Drug Hunter mailing list

to get free content and resources weekly. Trusted by > 5,500 drug hunters worldwide. Unsubscribe anytime.

Newsletter

nominate a molecule

Encountered an interesting new molecule? Let your community know!

become a reviewer

Get sneak previews of upcoming molecules and share your knowledge and expertise with the drug discovery community.

Molecules

Join the Drug Hunter mailing list

to get free content and resources weekly. Trusted by > 5,500 drug hunters worldwide. Unsubscribe anytime.

Newsletter

Join Subscribers from

…and hundreds more!